4Bauer KA. Laboratory markers of coagulation activation[J]. Arch Pathol Lab, 1998, 11:71-74.
5Hoek JA. Laboratory and clinical evaluation of an assay of thrombin-anti thrombin Ⅲ complexes [J]. Clin Chem, 1998, 34:2058-2061.
6Kjellberg U, Andersson NE, Rosen S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium [J]. Thromb Haemost,1999, 81(4) :527-531.
1Kaur G,Mishra S,Sehgal A,et al. Alterations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia [J]. Molecular & Cellu!.ar Biochemistry,2008,313(1-2) : 37-44.
2Wakatsuki A, Ikenoue NY,Shinohara K, et al. Lipoprotein particles in preeelampsia:susceptibility to oxidative modification[J]. Obstet- rics & Gynecology,2000,96(1) : 55-59.
3Vanhaecht K,Panella M,Van Zelm R,et al. An overview on the history and concept of care pathways as complex interventions[J]. International J Care Pathways ,2002,91(14) : 117-123.
4Sabine E. D-dimer testing in pregnancy [J]. Seminars in Vascular Medicine, 2005,5(4) : 375-8.
5Knijff EM,Gorrissen EJM,Velthuiste Wierik T,et al. Summary of contraindications to contraceptive [M]. New York:Parthenon Publishing Group, 2000 : 321.
6Min W,Lu S,Shuai L,et al. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer[J]. Clinica chimica acta; internatio- nal journal of clinical chemistry, 2013,425(1801 ) : 176-180.
7Nishii A,Noda Y,Nemoto R,et al. Evaluation of D-dimer during pregnancy [J]. Journal of Obstetrics & Gynaecology Research, 2009,35(4) : 689-693.
